携带KCNC2致病性变异癫痫患者的表型、遗传与功能特征谱
该研究通过外显子测序筛选KCNC2变异患者,进行临床、遗传及功能分析,在18例多种形式癫痫患者中鉴定出KCNC2变异,其中10个为新发变异、8个为修饰性变异;8例药物反应性患者使用丙戊酸单药或联合治疗实现无发作,功能分析显示3例严重DEE病例为功能获得、1例较轻表型GGE病例为功能缺失。
要点
- KCNC2是癫痫的新致病基因,其编码的Kv3.2通道对脑兴奋性调控至关重要。
- 18例患者涵盖遗传性全面性癫痫、发育性癫痫性脑病、局灶性癫痫和肌阵挛-失张力癫痫。
- 8例药物反应性患者使用丙戊酸单药或联合治疗实现无发作,包括严重DEE病例。
核心结论
- KCNC2是癫痫的新致病基因,Kv3.2在脑兴奋性调控中起关键作用。
研究设计与样本
- 通过外显子测序筛选KCNC2变异个体,经临床与科研合作转诊,进行临床、进一步遗传及功能分析;选取的新发变异在非洲爪蟾卵母细胞中进行电生理检查。
主要发现
- 在18例多种形式癫痫患者中鉴定出KCNC2新变异,包括遗传性全面性癫痫、发育性癫痫性脑病(含早发性失神癫痫)、局灶性癫痫和肌阵挛-失张力癫痫。
- 18个变异中10个为新发变异,8个分类为修饰性变异。
- 8例药物反应性患者使用丙戊酸单药或联合治疗实现无发作,包括严重DEE病例。
- 4个变异的功能分析显示3例严重DEE病例为功能获得,1例较轻表型遗传性全面性癫痫病例为功能缺失。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: KCNC2 encodes Kv3.2, a member of the Shaw-related (Kv3) voltage-gated potassium channel subfamily, which is important for sustained high-frequency firing and optimized energy efficiency of action potentials in the brain. The objective of this study was to analyze the clinical phenotype, genetic background, and biophysical function of disease-associated Kv3.2 variants. METHODS: Individuals with KCNC2 variants detected by exome sequencing were selected for clinical, further genetic, and functional analysis. Cases were referred through clinical and research collaborations. Selected de novo variants were examined electrophysiologically in Xenopus laevis oocytes. RESULTS: We identified novel KCNC2 variants in 18 patients with various forms of epilepsy, including genetic generalized epilepsy (GGE), developmental and epileptic encephalopathy (DEE) including early-onset absence epilepsy, focal epilepsy, and myoclonic-atonic epilepsy. Of the 18 variants, 10 were de novo and 8 were classified as modifying variants. Eight drug-responsive patients became seizure-free using valproic acid as monotherapy or in combination, including severe DEE cases. Functional analysis of 4 variants demonstrated gain of function in 3 severely affected DEE cases and loss of function in 1 case with a milder phenotype (GGE) as the underlying pathomechanisms. DISCUSSION: These findings implicate KCNC2 as a novel causative gene for epilepsy and emphasize the critical role of KV3.2 in the regulation of brain excitability.
引用
- Schwarz N, Seiffert S, Pendziwiat M, et al. Spectrum of Phenotypic, Genetic, and Functional Characteristics in Patients With Epilepsy With KCNC2 Pathogenic Variants. Neurology. 2022. PMID: 35314505. doi:10.1212/WNL.0000000000200660
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。